{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:09:43Z","timestamp":1784945383405,"version":"3.55.0"},"publisher-location":"Cham","reference-count":92,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030336783","type":"print"},{"value":"9783030336790","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/164_2019_268","type":"book-chapter","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T14:33:22Z","timestamp":1589898802000},"page":"147-165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The Rise and Fall of Kappa-Opioid Receptors in Drug Abuse Research"],"prefix":"10.1007","author":[{"given":"Matthew L.","family":"Banks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,29]]},"reference":[{"key":"268_CR1","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1016\/S0376-8716(03)00099-1","volume":"70","author":"NA Ator","year":"2003","unstructured":"Ator NA, Griffiths RR (2003) Principles of drug abuse liability assessment in laboratory animals. Drug Alcohol Depend 70:S55\u2013S72","journal-title":"Drug Alcohol Depend"},{"key":"268_CR2","first-page":"281768","volume":"2012","author":"ML Banks","year":"2012","unstructured":"Banks ML, Negus SS (2012) Preclinical determinants of drug choice under concurrent schedules of drug self-administration. Adv Pharmacol Sci 2012:281768","journal-title":"Adv Pharmacol Sci"},{"key":"268_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.tips.2016.11.002","volume":"38","author":"ML Banks","year":"2017","unstructured":"Banks ML, Negus SS (2017) Insights from preclinical choice models on treating drug addiction. Trends Pharmacol Sci 38:181\u2013194","journal-title":"Trends Pharmacol Sci"},{"key":"268_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s40501-015-0042-9","volume":"2","author":"ML Banks","year":"2015","unstructured":"Banks ML, Hutsell BA, Schwienteck KL, Negus SS (2015) Use of preclinical drug vs. food choice procedures to evaluate candidate medications for cocaine addiction. Curr Treat Options Psychiatry 2:136\u2013150","journal-title":"Curr Treat Options Psychiatry"},{"key":"268_CR5","doi-asserted-by":"crossref","unstructured":"Banks ML, Townsend EA, Negus SS (2019) Testing the 10 most wanted: a preclinical algorithm to screen candidate opioid use disorder medications. Neuropsychopharmacology","DOI":"10.1038\/s41386-019-0336-5"},{"key":"268_CR6","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/sj.npp.1300105","volume":"28","author":"CA Bowen","year":"2003","unstructured":"Bowen CA, Negus SS, Zong R, Neumeyer JL, Bidlack JM, Mello NK (2003) Effects of mixed-action \u03ba\/\u03bc opioids on cocaine self-administration and cocaine discrimination by rhesus monkeys. Neuropsychopharmacology 28:1125\u20131139","journal-title":"Neuropsychopharmacology"},{"key":"268_CR7","first-page":"1269","volume":"267","author":"ER Butelman","year":"1993","unstructured":"Butelman ER, Negus SS, Ai Y, de Costa BR, Woods JH (1993) Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys. J Pharmacol Exp Ther 267:1269\u20131276","journal-title":"J Pharmacol Exp Ther"},{"key":"268_CR8","first-page":"595","volume":"285","author":"ER Butelman","year":"1998","unstructured":"Butelman ER, Ko M-C, Sobczyk-Kojiro K, Mosberg HI, Van Bemmel B, Zernig G, Woods JH (1998) Kappa-opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception. J Pharmacol Exp Ther 285:595\u2013601","journal-title":"J Pharmacol Exp Ther"},{"key":"268_CR9","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1124\/jpet.105.092304","volume":"316","author":"WA Carlezon","year":"2006","unstructured":"Carlezon WA, B\u00e9guin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS, Rothman RB, Ma Z, Lee DY-W, Cohen BM (2006) Depressive-like effects of the \u03ba-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 316:440\u2013447","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"268_CR10","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.drugalcdep.2009.04.003","volume":"105","author":"LP Carter","year":"2009","unstructured":"Carter LP, Griffiths RR (2009) Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug Alcohol Depend 105(Suppl 1):S14\u2013S25","journal-title":"Drug Alcohol Depend"},{"key":"268_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1124\/jpet.114.214262","volume":"350","author":"JR Cashman","year":"2014","unstructured":"Cashman JR, Azar MR (2014) Potent inhibition of alcohol self-administration in alcohol-preferring rats by a \u03ba-opioid receptor antagonist. J Pharmacol Exp Ther 350:171\u2013180","journal-title":"J Pharmacol Exp Ther"},{"key":"268_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/npp.2015.258","volume":"41","author":"C Chavkin","year":"2015","unstructured":"Chavkin C, Koob GF (2015) Dynorphin, dysphoria, and dependence: the stress of addiction. Neuropsychopharmacology 41:373","journal-title":"Neuropsychopharmacology"},{"key":"268_CR13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1126\/science.6120570","volume":"215","author":"C Chavkin","year":"1982","unstructured":"Chavkin C, James I, Goldstein A (1982) Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215:413\u2013415","journal-title":"Science"},{"key":"268_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1601-183X.2012.00785.x","volume":"11","author":"T-K Clarke","year":"2012","unstructured":"Clarke T-K, Ambrose-Lanci L, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O\u2019Brien CP, Oslin DW, Lohoff FW (2012) Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction. Genes Brain Behav 11:415\u2013423","journal-title":"Genes Brain Behav"},{"key":"268_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2008.03.001","volume":"96","author":"SD Comer","year":"2008","unstructured":"Comer SD, Ashworth JB, Foltin RW, Johanson CE, Zacny JP, Walsh SL (2008) The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend 96:1\u201315","journal-title":"Drug Alcohol Depend"},{"key":"268_CR16","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1124\/jpet.301.3.993","volume":"301","author":"KP Cosgrove","year":"2002","unstructured":"Cosgrove KP, Carroll ME (2002) Effects of bremazocine on self-administration of smoked cocaine base and orally delivered ethanol, phencyclidine, saccharin, and food in rhesus monkeys: a behavioral economic analysis. J Pharmacol Exp Ther 301:993\u20131002","journal-title":"J Pharmacol Exp Ther"},{"key":"268_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.pnpbp.2015.01.001","volume":"62","author":"NA Crowley","year":"2015","unstructured":"Crowley NA, Kash TL (2015) Kappa opioid receptor signaling in the brain: circuitry and implications for treatment. Prog Neuro-Psychopharmacol Biol Psychiatry 62:51\u201360","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"268_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1124\/pr.115.011668","volume":"68","author":"PW Czoty","year":"2016","unstructured":"Czoty PW, Stoops WW, Rush CR (2016) Evaluation of the \u201cPipeline\u201d for development of medications for cocaine use disorder: a review of translational preclinical, human laboratory, and clinical trial research. Pharmacol Rev 68:533\u2013562","journal-title":"Pharmacol Rev"},{"key":"268_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00001756-199305000-00020","volume":"4","author":"JB Daunais","year":"1993","unstructured":"Daunais JB, Roberts DC, McGinty JF (1993) Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum. Neuroreport 4:543\u2013546","journal-title":"Neuroreport"},{"key":"268_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.pbb.2012.03.006","volume":"101","author":"GA Deehan","year":"2012","unstructured":"Deehan GA, McKinzie DL, Carroll FI, McBride WJ, Rodd ZA (2012) The long-lasting effects of JDTic, a kappa opioid receptor antagonist, on the expression of ethanol-seeking behavior and the relapse drinking of female alcohol-preferring (P) rats. Pharmacol Biochem Behav 101:581\u2013587","journal-title":"Pharmacol Biochem Behav"},{"key":"268_CR21","first-page":"1236","volume":"266","author":"DP Devine","year":"1993","unstructured":"Devine DP, Leone P, Pocock D, Wise RA (1993) Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther 266:1236\u20131246","journal-title":"J Pharmacol Exp Ther"},{"key":"268_CR22","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","volume":"85","author":"G Di Chiara","year":"1988","unstructured":"Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85:5274\u20135278","journal-title":"Proc Natl Acad Sci U S A"},{"key":"268_CR23","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/s41386-018-0015-y","volume":"43","author":"E Domi","year":"2018","unstructured":"Domi E, Barbier E, Augier E, Augier G, Gehlert D, Barchiesi R, Thorsell A, Holm L, Heilig M (2018) Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders. Neuropsychopharmacology 43:1805\u20131812","journal-title":"Neuropsychopharmacology"},{"key":"268_CR24","first-page":"193","volume":"78","author":"BA Donzanti","year":"1992","unstructured":"Donzanti BA, Althaus JS, Payson MM, Von Voigtlander PF (1992) Kappa agonist-induced reduction in dopamine release: site of action and tolerance. Res Commun Chem Pathol Pharmacol 78:193\u2013210","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"268_CR25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.neuropharm.2006.04.005","volume":"51","author":"WM Doyon","year":"2006","unstructured":"Doyon WM, Howard EC, Shippenberg TS, Gonzales RA (2006) \u03ba-Opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration. Neuropharmacology 51:487\u2013496","journal-title":"Neuropharmacology"},{"key":"268_CR26","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1046\/j.1460-9568.2003.02636.x","volume":"17","author":"P Fagergren","year":"2003","unstructured":"Fagergren P, Smith HR, Daunais JB, Nader MA, Porrino LJ, Hurd YL (2003) Temporal upregulation of prodynorphin mRNA in the primate striatum after cocaine self-administration. Eur J Neurosci 17:2212\u20132218","journal-title":"Eur J Neurosci"},{"key":"268_CR27","doi-asserted-by":"publisher","DOI":"10.1037\/10627-000","volume-title":"Schedules of reinforcement","author":"C Ferster","year":"1957","unstructured":"Ferster C, Skinner B (1957) Schedules of reinforcement. Appleton-Century-Croft, New York"},{"key":"268_CR28","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1007\/s00213-014-3436-2","volume":"231","author":"KB Freeman","year":"2014","unstructured":"Freeman KB, Naylor JE, Prisinzano TE, Woolverton WL (2014) Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeys. Psychopharmacology 231:2751\u20132758","journal-title":"Psychopharmacology"},{"key":"268_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0006-8993(95)00306-B","volume":"681","author":"SD Glick","year":"1995","unstructured":"Glick SD, Maisonneuve IM, Raucci J, Sydney A (1995) Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res 681:147\u2013152","journal-title":"Brain Res"},{"key":"268_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0014-2999(98)00548-2","volume":"357","author":"SD Glick","year":"1998","unstructured":"Glick SD, Visker KE, Maisonneuve IM (1998) Effects of cyclazocine on cocaine self-administration in rats. Eur J Pharmacol 357:9\u201314","journal-title":"Eur J Pharmacol"},{"key":"268_CR31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00213-008-1079-x","volume":"199","author":"M Haney","year":"2008","unstructured":"Haney M, Spealman R (2008a) Controversies in translational research: drug self-administration. Psychopharmacology 199:403\u2013419","journal-title":"Psychopharmacology"},{"key":"268_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00213-008-1079-x","volume":"199","author":"M Haney","year":"2008","unstructured":"Haney M, Spealman R (2008b) Controversies in translational research: drug self-administration. Psychopharmacology 199:403\u2013419","journal-title":"Psychopharmacology"},{"key":"268_CR33","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ejmech.2017.10.012","volume":"141","author":"MA Helal","year":"2017","unstructured":"Helal MA, Habib ES, Chittiboyina AG (2017) Selective kappa opioid antagonists for treatment of addiction, are we there yet? Eur J Med Chem 141:632\u2013647","journal-title":"Eur J Med Chem"},{"key":"268_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF00427134","volume":"62","author":"F Hoffmeister","year":"1979","unstructured":"Hoffmeister F (1979) Progressive-ratio performance in the rhesus monkey maintained by opiate infusions. Psychopharmacology 62:181\u2013186","journal-title":"Psychopharmacology"},{"key":"268_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s002130000601","volume":"153","author":"SM H\u00f6lter","year":"2000","unstructured":"H\u00f6lter SM, Henniger MSH, Lipkowski AW, Spanagel R (2000) Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats. Psychopharmacology 153:93\u2013102","journal-title":"Psychopharmacology"},{"key":"268_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1476-5381.1990.tb12110.x","volume":"101","author":"JC Hunter","year":"1990","unstructured":"Hunter JC, Leighton GE, Meecham KG, Boyle SJ, Horwell DC, Rees DC, Hughes J (1990) CI-977, a novel and selective agonist for the \u03ba-opioid receptor. Br J Pharmacol 101:183\u2013189","journal-title":"Br J Pharmacol"},{"key":"268_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/syn.890130408","volume":"13","author":"YL Hurd","year":"1993","unstructured":"Hurd YL, Herkenham M (1993) Molecular alterations in the neostriatum of human cocaine addicts. Synapse 13:357\u2013369","journal-title":"Synapse"},{"key":"268_CR38","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/adb.12206","volume":"00","author":"BA Hutsell","year":"2016","unstructured":"Hutsell BA, Cheng K, Rice KC, Negus SS, Banks ML (2016) Effects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys. Addict Biol 00:360\u2013373","journal-title":"Addict Biol"},{"key":"268_CR39","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00213-010-1845-4","volume":"210","author":"N Ismayilova","year":"2010","unstructured":"Ismayilova N, Shoaib M (2010) Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats. Psychopharmacology 210:211\u2013220","journal-title":"Psychopharmacology"},{"key":"268_CR40","doi-asserted-by":"crossref","unstructured":"Jones JD, Babalonis S, Marcus R, Vince B, Kelsh D, Lofwall MR, Fraser H, Paterson B, Martinez S, Martinez DM, Nunes EV, Walsh SL, Comer SD (2019) A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior. Addict Biol 0: e12799","DOI":"10.1111\/adb.12799"},{"key":"268_CR41","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1176\/appi.ajp.2007.05030503","volume":"164","author":"GF Koob","year":"2007","unstructured":"Koob GF, Kreek MJ (2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatr 164:1149\u20131159","journal-title":"Am J Psychiatr"},{"key":"268_CR42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-pharmtox-010715-103143","volume":"56","author":"GF Koob","year":"2016","unstructured":"Koob GF, Mason BJ (2016) Existing and future drugs for the treatment of the dark side of addiction. Ann Rev Pharmacol Toxicol 56:299\u2013322","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"268_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.psych.59.103006.093548","volume":"59","author":"GF Koob","year":"2008","unstructured":"Koob GF, Moal ML (2008) Addiction and the brain antireward system. Annu Rev Psychol 59:29\u201353","journal-title":"Annu Rev Psychol"},{"key":"268_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/npp.2009.110","volume":"35","author":"GF Koob","year":"2009","unstructured":"Koob GF, Volkow ND (2009) Neurocircuitry of addiction. Neuropsychopharmacology 35:217","journal-title":"Neuropsychopharmacology"},{"key":"268_CR45","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0014-2999(96)00961-2","volume":"321","author":"AV Kuzmin","year":"1997","unstructured":"Kuzmin AV, Semenova S, Gerrits MAFM, Zvartau EE, Van Ree JM (1997) \u03ba-Opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice. Eur J Pharmacol 321:265\u2013271","journal-title":"Eur J Pharmacol"},{"key":"268_CR1000","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0014-2999(98)00637-2","volume":"358","author":"AV Kuzmin","year":"1998","unstructured":"Kuzmin AV, Gerrits MA, Van Ree JM (1998) Kappa-opioid receptor blockade with nor-binaltorphimine modulates cocaine self-administration in drug-naive rats. Eur J Pharmacol 358:197\u2013202","journal-title":"Eur J Pharmacol"},{"key":"268_CR46","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/npp.2013.236","volume":"39","author":"MD Leitl","year":"2014","unstructured":"Leitl MD, Onvani S, Bowers MS, Cheng K, Rice KC, Carlezon WA Jr, Banks ML, Negus SS (2014) Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous kappa-opioids. Neuropsychopharmacology 39:614\u2013624","journal-title":"Neuropsychopharmacology"},{"key":"268_CR47","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1111\/add.13375","volume":"111","author":"W Ling","year":"2016","unstructured":"Ling W, Hillhouse MP, Saxon AJ, Mooney LJ, Thomas CM, Ang A, Matthews AG, Hasson A, Annon J, Sparenborg S, Liu DS, McCormack J, Church S, Swafford W, Drexler K, Schuman C, Ross S, Wiest K, Korthuis PT, Lawson W, Brigham GS, Knox PC, Dawes M, Rotrosen J (2016) Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the cocaine use reduction with buprenorphine (CURB) study. Addiction 111:1416\u20131427","journal-title":"Addiction"},{"key":"268_CR48","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.pnpbp.2010.10.007","volume":"35","author":"X Liu","year":"2011","unstructured":"Liu X, Jernigan C (2011) Activation of the opioid \u03bc1, but not \u03b4 or \u03ba, receptors is required for nicotine reinforcement in a rat model of drug self-administration. Prog Neuro-Psychopharmacol Biol Psychiatry 35:146\u2013153","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"268_CR49","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1046\/j.1460-9568.1998.00340.x","volume":"10","author":"M Marinelli","year":"1998","unstructured":"Marinelli M, Barrot M, Simon H, Oberlander C, Dekeyne A, Moal ML, Piazza PV (1998) Pharmacological stimuli decreasing nucleus accumbens dopamine can act as positive reinforcers but have a low addictive potential. Eur J Neurosci 10:3269\u20133275","journal-title":"Eur J Neurosci"},{"key":"268_CR50","doi-asserted-by":"crossref","unstructured":"Martinez D, Slifstein M, Matuskey D, Nabulsi N, Zheng M-Q, Lin S-f, Ropchan J, Urban N, Grassetti A, Chang D, Salling M, Foltin R, Carson RE, Huang Y (2019) Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study. Neuropsychopharmacology","DOI":"10.1038\/s41386-019-0398-4"},{"key":"268_CR51","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0893-133X(95)00274-H","volume":"14","author":"NK Mello","year":"1996","unstructured":"Mello NK, Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375\u2013424","journal-title":"Neuropsychopharmacology"},{"key":"268_CR52","first-page":"812","volume":"286","author":"NK Mello","year":"1998","unstructured":"Mello NK, Negus SS (1998) Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys. J Pharmacol Exp Ther 286:812\u2013824","journal-title":"J Pharmacol Exp Ther"},{"key":"268_CR53","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s00213-005-0067-7","volume":"182","author":"JM Mitchell","year":"2005","unstructured":"Mitchell JM, Liang MT, Fields HL (2005) A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats. Psychopharmacology 182:384\u2013392","journal-title":"Psychopharmacology"},{"key":"268_CR1001","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/dev.21137","volume":"56","author":"M Morales","year":"2014","unstructured":"Morales M, Anderson RI, Spear LP, El V (2014) Effects of the kappa opioid receptor antagonist, norbinaltorphimine, on ethanol intake: impact of age and sex. Dev Psychobiol 56:700\u2013712","journal-title":"Dev Psychobiol"},{"key":"268_CR54","doi-asserted-by":"publisher","first-page":"e70701","DOI":"10.1371\/journal.pone.0070701","volume":"8","author":"TA Munro","year":"2013","unstructured":"Munro TA, Huang X-P, Inglese C, Perrone MG, Van't Veer A, Carroll FI, B\u00e9guin C, Carlezon WA Jr, Colabufo NA, Cohen BM, Roth BL (2013) Selective \u03ba opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters. PLoS One 8:e70701","journal-title":"PLoS One"},{"key":"268_CR55","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1016\/j.bmcl.2012.05.122","volume":"22","author":"H Nagase","year":"2012","unstructured":"Nagase H, Imaide S, Hirayama S, Nemoto T, Fujii H (2012) Essential structure of opioid \u03ba receptor agonist nalfurafine for binding to the \u03ba receptor 2: synthesis of decahydro(iminoethano)phenanthrene derivatives and their pharmacologies. Bioorg Med Chem Letts 22:5071\u20135074","journal-title":"Bioorg Med Chem Letts"},{"key":"268_CR56","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00213-004-1878-7","volume":"176","author":"SS Negus","year":"2004","unstructured":"Negus SS (2004) Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys. Psychopharmacology 176:204\u2013213","journal-title":"Psychopharmacology"},{"key":"268_CR57","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pbb.2017.04.006","volume":"164","author":"S. Stevens Negus","year":"2018","unstructured":"Negus SS, Banks ML (2018) Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: implications for negative reinforcement as a driver of addiction and target for medications development. Pharmacol Biochem Behav 164:32\u201339","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"268_CR58","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/npp.2008.127","volume":"34","author":"SS Negus","year":"2009","unstructured":"Negus SS, Rice KC (2009) Mechanisms of withdrawal-associated increases in heroin self-administration: pharmacologic modulation of heroin vs food choice in heroin-dependent rhesus monkeys. Neuropsychopharmacology 34:899\u2013911","journal-title":"Neuropsychopharmacology"},{"key":"268_CR59","first-page":"1245","volume":"265","author":"SS Negus","year":"1993","unstructured":"Negus SS, Henriksen SJ, Mattox A, Pasternak GW, Portoghese PS, Takemori AE, Weinger MB, Koob GF (1993) Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats. J Pharmacol Exp Ther 265:1245\u20131252","journal-title":"J Pharmacol Exp Ther"},{"key":"268_CR60","first-page":"44","volume":"282","author":"SS Negus","year":"1997","unstructured":"Negus SS, Mello NK, Portoghese PS, Lin C-E (1997) Effects of kappa opioids on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 282:44\u201355","journal-title":"J Pharmacol Exp Ther"},{"key":"268_CR61","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1037\/a0013088","volume":"16","author":"SS Negus","year":"2008","unstructured":"Negus SS, Schrode K, Stevenson GW (2008) Mu\/kappa opioid interactions in rhesus monkeys: implications for analgesia and abuse liability. Exp Clin Psychopharmacol 16:386\u2013399","journal-title":"Exp Clin Psychopharmacol"},{"key":"268_CR62","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s002130050894","volume":"142","author":"P Nestby","year":"1999","unstructured":"Nestby P, Schoffelmeer ANM, Homberg JR, Wardeh G, De Vries TJ, Mulder AH, Vanderschuren LJMJ (1999) Bremazocine reduces unrestricted free-choice ethanol self-administration in rats without affecting sucrose preference. Psychopharmacology 142:309\u2013317","journal-title":"Psychopharmacology"},{"key":"268_CR63","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0014-2999(82)90008-5","volume":"77","author":"T Oka","year":"1982","unstructured":"Oka T, Negishi K, Suda M, Sawa A, Fujino M, Wakimasu M (1982) Evidence that dynorphin-(1\u201313) acts as an agonist on opioid \u03ba-receptors. Eur J Pharmacol 77:137\u2013141","journal-title":"Eur J Pharmacol"},{"key":"268_CR64","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1126\/science.3016896","volume":"233","author":"A Pfeiffer","year":"1986","unstructured":"Pfeiffer A, Brantl V, Herz A, Emrich H (1986) Psychotomimesis mediated by kappa opiate receptors. Science 233:774\u2013776","journal-title":"Science"},{"key":"268_CR1002","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41386-018-0292-5","volume":"44","author":"K Rasmussen","year":"2019","unstructured":"Rasmussen K, White DA, Acri JB (2019) NIDA\u2019s medication development priorities in response to the opioid crisis: ten most wanted. Neuropsychopharmacology 44:657\u2013659","journal-title":"Neuropsychopharmacology"},{"key":"268_CR65","first-page":"330","volume":"45","author":"K Raynor","year":"1994","unstructured":"Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, Reisine T (1994) Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol 45:330\u2013334","journal-title":"Mol Pharmacol"},{"key":"268_CR66","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/npp.2017.205","volume":"43","author":"B Reed","year":"2017","unstructured":"Reed B, Butelman ER, Fry RS, Kimani R, Kreek MJ (2017) Repeated administration of opra kappa (LY2456302), a novel, short-acting, selective KOP-r antagonist, in persons with and without cocaine dependence. Neuropsychopharmacology 43:739","journal-title":"Neuropsychopharmacology"},{"key":"268_CR67","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neuropharm.2013.09.021","volume":"77","author":"LM Rorick-Kehn","year":"2014","unstructured":"Rorick-Kehn LM, Witkin JM, Statnick MA, Eberle EL, McKinzie JH, Kahl SD, Forster BM, Wong CJ, Li X, Crile RS, Shaw DB, Sahr AE, Adams BL, Quimby SJ, Diaz N, Jimenez A, Pedregal C, Mitch CH, Knopp KL, Anderson WH, Cramer JW, McKinzie DL (2014) LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders. Neuropharmacology 77:131\u2013144","journal-title":"Neuropharmacology"},{"key":"268_CR68","doi-asserted-by":"publisher","first-page":"11934","DOI":"10.1073\/pnas.182234399","volume":"99","author":"BL Roth","year":"2002","unstructured":"Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB (2002) Salvinorin A: a potent naturally occurring nonnitrogenous \u03ba opioid selective agonist. Proc Natl Acad Sci U S A 99:11934\u201311939","journal-title":"Proc Natl Acad Sci U S A"},{"key":"268_CR69","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1369-1600.2012.00455.x","volume":"17","author":"JR Schank","year":"2012","unstructured":"Schank JR, Goldstein AL, Rowe KE, King CE, Marusich JA, Wiley JL, Carroll FI, Thorsell A, Heilig M (2012) The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety. Addict Biol 17:634\u2013647","journal-title":"Addict Biol"},{"key":"268_CR70","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s002130051016","volume":"144","author":"S Schenk","year":"1999","unstructured":"Schenk S, Partridge B, Shippenberg TS (1999) U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology 144:339\u2013346","journal-title":"Psychopharmacology"},{"key":"268_CR71","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0893-133X(00)00190-1","volume":"24","author":"S Schenk","year":"2001","unstructured":"Schenk S, Partridge B, Shippenberg TS (2001) Effects of the kappa-opioid receptor agonist, U69593, on the development of sensitization and on the maintenance of cocaine self-administration. Neuropsychopharmacology 24:441","journal-title":"Neuropsychopharmacology"},{"key":"268_CR72","doi-asserted-by":"publisher","first-page":"19384","DOI":"10.1523\/JNEUROSCI.1979-13.2013","volume":"33","author":"JE Schlosburg","year":"2013","unstructured":"Schlosburg JE, Whitfield TW, Park PE, Crawford EF, George O, Vendruscolo LF, Koob GF (2013) Long-term antagonism of \u03ba opioid receptors prevents escalation of and increased motivation for heroin intake. J Neurosci 33:19384\u201319392","journal-title":"J Neurosci"},{"key":"268_CR73","doi-asserted-by":"publisher","first-page":"22387","DOI":"10.1074\/jbc.M113.476234","volume":"288","author":"CL Schmid","year":"2013","unstructured":"Schmid CL, Streicher JM, Groer CE, Munro TA, Zhou L, Bohn LM (2013) Functional selectivity of 6\u2032-guanidinonaltrindole (6\u2032-GNTI) at \u03ba-opioid receptors in striatal neurons. J Biol Chem 288:22387\u201322398","journal-title":"J Biol Chem"},{"key":"268_CR74","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.pharmthera.2007.06.011","volume":"116","author":"TS Shippenberg","year":"2007","unstructured":"Shippenberg TS, Zapata A, Chefer VI (2007) Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther 116:306\u2013321","journal-title":"Pharmacol Ther"},{"key":"268_CR75","volume-title":"The behavior of organisms","author":"B Skinner","year":"1938","unstructured":"Skinner B (1938) The behavior of organisms. Appleton-Century-Crofts, New York"},{"key":"268_CR76","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.brainres.2008.12.002","volume":"1255","author":"W Solecki","year":"2009","unstructured":"Solecki W, Ziolkowska B, Krowka T, Gieryk A, Filip M, Przewlocki R (2009) Alterations of prodynorphin gene expression in the rat mesocorticolimbic system during heroin self-administration. Brain Res 1255:113\u2013121","journal-title":"Brain Res"},{"key":"268_CR77","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1111\/j.1471-4159.1990.tb04963.x","volume":"55","author":"R Spanagel","year":"1990","unstructured":"Spanagel R, Herz A, Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55:1734\u20131740","journal-title":"J Neurochem"},{"key":"268_CR78","doi-asserted-by":"publisher","first-page":"8225","DOI":"10.1523\/JNEUROSCI.17-21-08225.1997","volume":"17","author":"JK Staley","year":"1997","unstructured":"Staley JK, Rothman RB, Rice KC, Partilla J, Mash DC (1997) \u03ba2 opioid receptors in limbic areas of the human brain are upregulated by cocaine in fatal overdose victims. J Neurosci 17:8225\u20138233","journal-title":"J Neurosci"},{"key":"268_CR79","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/BF00428193","volume":"85","author":"AH Tang","year":"1985","unstructured":"Tang AH, Collins RJ (1985) Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys. Psychopharmacology 85:309\u2013314","journal-title":"Psychopharmacology"},{"key":"268_CR80","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.brainres.2018.09.023","volume":"1713","author":"HA Tejeda","year":"2019","unstructured":"Tejeda HA, Bonci A (2019) Dynorphin\/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders. Brain Res 1713:91\u2013101","journal-title":"Brain Res"},{"key":"268_CR81","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00213-017-4652-3","volume":"234","author":"EA Townsend","year":"2017","unstructured":"Townsend EA, Naylor JE, Negus SS, Edwards SR, Qureshi HN, McLendon HW, McCurdy CR, Kapanda CN, do Carmo JM, da Silva FS, Hall JE, Sufka KJ, Freeman KB (2017) Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats. Psychopharmacology 234:2597\u20132605","journal-title":"Psychopharmacology"},{"key":"268_CR82","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1369-1600.2010.00226.x","volume":"16","author":"BM Walker","year":"2011","unstructured":"Walker BM, Zorrilla EP, Koob GF (2011) Systemic \u03ba-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats. Addict Biol 16:116\u2013119","journal-title":"Addict Biol"},{"key":"268_CR83","first-page":"147","volume":"299","author":"SL Walsh","year":"2001","unstructured":"Walsh SL, Geter-Douglas B, Strain EC, Bigelow GE (2001) Enadoline and butorphanol: evaluation of \u03ba-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. J Pharmacol Exp Ther 299:147\u2013158","journal-title":"J Pharmacol Exp Ther"},{"key":"268_CR84","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00213-010-1825-8","volume":"210","author":"S Wee","year":"2010","unstructured":"Wee S, Koob G (2010a) The role of the dynorphin\u2013\u03ba opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology 210:121\u2013135","journal-title":"Psychopharmacology"},{"key":"268_CR85","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00213-010-1825-8","volume":"210","author":"S Wee","year":"2010","unstructured":"Wee S, Koob GF (2010b) The role of the dynorphin\u2013\u03ba opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology 210:121\u2013135","journal-title":"Psychopharmacology"},{"key":"268_CR86","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00213-009-1563-y","volume":"205","author":"S Wee","year":"2009","unstructured":"Wee S, Orio L, Ghirmai S, Cashman J, Koob G (2009) Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine. Psychopharmacology 205:565\u2013575","journal-title":"Psychopharmacology"},{"key":"268_CR87","doi-asserted-by":"publisher","first-page":"146ra110","DOI":"10.1126\/scitranslmed.3003948","volume":"4","author":"S Wee","year":"2012","unstructured":"Wee S, Vendruscolo LF, Misra KK, Schlosburg JE, Koob GF (2012) A combination of buprenorphine and naltrexone blocks compulsive cocaine intake in rodents without producing dependence. Science Transl Med 4:146ra110","journal-title":"Science Transl Med"},{"key":"268_CR88","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1523\/JNEUROSCI.1978-13.2015","volume":"35","author":"TW Whitfield","year":"2015","unstructured":"Whitfield TW, Schlosburg JE, Wee S, Gould A, George O, Grant Y, Zamora-Martinez ER, Edwards S, Crawford E, Vendruscolo LF, Koob GF (2015) \u03ba opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake. J Neurosci 35:4296\u20134305","journal-title":"J Neurosci"},{"key":"268_CR89","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0376-8716(85)90059-6","volume":"14","author":"JH Woods","year":"1985","unstructured":"Woods JH, Gmerek DE (1985) Substitution and primary dependence studies in animals. Drug Alcohol Depend 14:233\u2013247","journal-title":"Drug Alcohol Depend"}],"container-title":["Handbook of Experimental Pharmacology","Substance Use Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2019_268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T23:05:18Z","timestamp":1593299118000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2019_268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030336783","9783030336790"],"references-count":92,"URL":"https:\/\/doi.org\/10.1007\/164_2019_268","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"29 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}